Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings.
Vol 23, No 16S (June 1 Supplement), 2005: 7318
© 2005 American Society of Clinical Oncology

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Janbay, N. Articles by Maroules, M. Search for Related Content PubMed Articles by Janbay, N. Articles by Maroules, M.

Abstract

Non-small cell lung cancer (NSCLCA): Does the size of the tumor and the patient’s age predict brain metastases?

St. Joseph’s Regional Medcl Ctr, Paterson, NJ; St. Michael’s Medcl Ctr, Newark, NJ

7318

Background: Many studies have demonstrated the prognostic importance of tumor size in the early stages of NSCLCA and the effect of age on the outcome; however, no study has looked at the association between brain metastases and the size of the tumor or the age of the patient. Subjects and Methods: We retrospectively analyzed 251 cases that were diagnosed with NSCLCA over a period of five years (1999–2003) in two institutions. We looked at many aspects at the presentation of the disease in an effort to predict brain metastases: age of the patients, size of the tumor, hilar involvement, pleural effusion, and pathology of the tumor. 88 patients (35%) were 60 years old. 82 patients (32.7%)had a tumor size 3 cm, 146 (58%) had tumor >3 cm, 16 (6.4%) had massive plural effusion, and 7 (2.8%) were presented with lung collapse. Hilar and pleural involvement occurred in 127 (51%) and 83 patients (33%), respectively. Histology showed adenocarcenoma in 194 patients (77%), squamous cell carcinoma in 51 (20%), and large cell carcinoma in 6 (3%). Results: A total of 44 cases of brain metastasis were found at the time of diagnosis, and of these, 24 (55%) were <60 years old. Compared to the patients >60 years old, there was a statistically significant increase in the incidence of brain metastasis by using chi-squar test (p=0.0029), and by using linear regression analysis there was a high significance of age predicting brain metastases (p<0.05). There was no significance when comparing the incidence of brain metastases to a primary tumor size 3 cm, (p=0.2668), Hilar involvement (p= 0.2147), or pleural effusion (p=0.3683). However, there was a statistical significance when comparing the incidence of brain mets with the pathology (adenocarcenoma) of the tumor (p=0.01). Conclusion: Our analysis suggests that younger pts. (60 years) have a higher chance to present with brain mets then older pts. (>60), the pathology of the tumor (adenocarcenoma) has a high chance to metastasize, and the size of the tumor does not predict brain mets.

No significant financial relationships to disclose.